Cargando…

A new serotonin 5-HT(6) receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding

Serotonin 5-HT(6) receptor has been proposed as a promising therapeutic target for cognition enhancement though the development of new antagonists is still needed to validate these molecules as a drug class for the treatment of Alzheimer’s disease and other pathologies associated with memory deficie...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Vera, Juan A., Medina, Rocío A., Martín-Fontecha, Mar, Gonzalez, Angel, de la Fuente, Tania, Vázquez-Villa, Henar, García-Cárceles, Javier, Botta, Joaquín, McCormick, Peter J., Benhamú, Bellinda, Pardo, Leonardo, López-Rodríguez, María L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259792/ https://www.ncbi.nlm.nih.gov/pubmed/28117458 http://dx.doi.org/10.1038/srep41293

Ejemplares similares

New Trends in Aging Drug Discovery
por: Benhamú, Bellinda, et al.
Publicado: (2022)

Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT(3) and 5-HT(6) Receptor Antagonist with Antipsychotic and Procognitive Properties
por: Zajdel, Paweł, et al.
Publicado: (2021)

The Phenoxyalkyltriazine Antagonists for 5-HT(6) Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases
por: Sudoł, Sylwia, et al.
Publicado: (2021)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

N-Skatyltryptamines—Dual 5-HT(6)R/D(2)R Ligands with Antipsychotic and Procognitive Potential
por: Hogendorf, Agata, et al.
Publicado: (2021)

The procognitive effects of leptin in the brain and their clinical implications
por: Paz-Filho, G, et al.
Publicado: (2010)

Shilajit: A Natural Phytocomplex with Potential Procognitive Activity
por: Carrasco-Gallardo, Carlos, et al.
Publicado: (2012)

Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
por: Murao, Satoshi, et al.
Publicado: (2010)

Procognitive impact of ciproxifan (a histaminergic H(3) receptor antagonist) on contextual memory retrieval after acute stress
por: Chauveau, Frédéric, et al.
Publicado: (2019)

Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT(3A) and 5-HT(6) receptor subtypes
por: Vitalis, Tania, et al.
Publicado: (2013)

Concise and Scalable Radiosynthesis of (+)-[(18)F]MDL100907 as a Serotonin 5-HT(2A) Receptor Antagonist for PET
por: Chavan, Lahu N., et al.
Publicado: (2023)

Serotonin (5-HT(3)) receptor antagonists for the reduction of symptoms of low anterior resection syndrome
por: Itagaki, Ryohei, et al.
Publicado: (2014)

Mechanisms of the Procognitive Effects of Xanthotoxin and Umbelliferone on LPS-Induced Amnesia in Mice
por: Kurach, Łukasz, et al.
Publicado: (2021)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Development of Fluorescent Probes that Target Serotonin 5-HT(2B) Receptors
por: Azuaje, Jhonny, et al.
Publicado: (2017)

Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?
por: Geyer, Mark A.
Publicado: (2006)

1-Aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats
por: Popik, Piotr, et al.
Publicado: (2014)

2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D(1) Receptor for Parkinson’s Disease
por: García-Cárceles, Javier, et al.
Publicado: (2022)

The Antidepressant 5-HT(2A) Receptor Antagonists Pizotifen and Cyproheptadine Inhibit Serotonin-Enhanced Platelet Function
por: Lin, Olivia A., et al.
Publicado: (2014)

Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
por: Li, Xiaojiao, et al.
Publicado: (2021)

Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats
por: Papp, Mariusz, et al.
Publicado: (2016)

Neurogenic-dependent changes in hippocampal circuitry underlie the procognitive effect of exercise in aging mice
por: Zhou, Xiaoqing Alice, et al.
Publicado: (2021)

Supplementation of Regular Diet With Medium-Chain Triglycerides for Procognitive Effects: A Narrative Review
por: Shcherbakova, Ksenia, et al.
Publicado: (2022)

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
por: Neumann, Joachim, et al.
Publicado: (2023)

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB(1) and Serotonin 5-HT(2A) Receptors
por: Viñals, Xavier, et al.
Publicado: (2015)

Can 5-HT(3) Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order
por: Rojas-Fernandez, Carlos H.
Publicado: (2014)

The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites
por: Andreu, José M., et al.
Publicado: (2022)

An NO Donor Approach to Neuroprotective and Procognitive Estrogen Therapy Overcomes Loss of NO Synthase Function and Potentially Thrombotic Risk
por: VandeVrede, Lawren, et al.
Publicado: (2013)

Comparative safety of serotonin (5-HT(3)) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2015)

Comparative efficacy of serotonin (5-HT(3)) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis
por: Tricco, Andrea C., et al.
Publicado: (2015)

Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT(1A) Serotonin Receptor Antagonists
por: Ostrowska, Kinga, et al.
Publicado: (2021)

Computational approaches for the design of novel dopamine D(2) and serotonin 5-HT(2A) receptor dual antagonist towards schizophrenia
por: Rathore, Akash, et al.
Publicado: (2022)

Biophysical validation of serotonin 5-HT(2A) and 5-HT(2C) receptor interaction
por: Felsing, Daniel E., et al.
Publicado: (2018)

Conservation of 5-HT(1A) receptor-mediated autoinhibition of serotonin (5-HT) neurons in mice with altered 5-HT homeostasis
por: Araragi, Naozumi, et al.
Publicado: (2013)

Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia
por: Johnston, Jewel L., et al.
Publicado: (2022)

Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for “Diabesity”
por: Decara, Juan M., et al.
Publicado: (2022)

Role of Serotonin via 5-HT(2B) Receptors in the Reinforcing Effects of MDMA in Mice
por: Doly, Stéphane, et al.
Publicado: (2009)

Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2013)

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
por: Tricco, Andrea C, et al.
Publicado: (2015)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_qmor5ekra01l3utubntpedtsfs